# Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

> **NCT01128816** · NA · TERMINATED · sponsor: **Toronto Rehabilitation Institute** · enrollment: 732 (actual)

## Conditions studied

- Sleep Apnea
- Heart Failure

## Interventions

- **DEVICE:** Adaptive Servo Ventilation

## Key facts

- **NCT ID:** NCT01128816
- **Lead sponsor:** Toronto Rehabilitation Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 732 (ACTUAL)
- **Why stopped:** Philips Global Field Safety Notice for PAP Devices \& Ventilators, June 14, 2021 (June 15, 2021 censor date for trial). Patient final visits and collection of endpoints prior to censor date continued to March 31, 2022.
- **Last updated:** 2022-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128816, "Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01128816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*